1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-158

PAR-25-158National Institutes of HealthR61

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Deadline
Award ceiling
Not stated
Awards
Not stated
Posted
Nov 25, 2024

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 3 standing review criteria here, free with an account. Create free account

Summary

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan…

Related NIH announcements3

Companion announcements with the same title first, then other open R61 announcements on related subjects with at least two weeks to go.

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

PAR-25-159National Institutes of Health3 review criteria on fileagency framework

—

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

RFA-NS-25-023National Institutes of Health4 review criteria on file

$350k

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

RFA-DA-27-016National Institutes of Health3 review criteria on file

—

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 3 standing review criteria National Institutes of Health applies to this kind of proposal (its standard framework, not criteria written for this announcement)

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria
Create free accountSign in

No card required. Browsing is free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-057National Institutes of Health6 review criteria on file

—

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

RFA-DK-27-108National Institutes of Health3 review criteria on fileagency framework

$500k

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

RFA-DK-27-139National Institutes of Health

—

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

RFA-DK-27-112National Institutes of Health

—

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Substance use), with at least two weeks to apply.

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

PAR-24-089National Institutes of Health5 review criteria on fileagency framework

$750k

D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)

PAS-25-236National Institutes of Health3 review criteria on fileagency framework

—

OJJDP FY 2026 Opioid Affected Youth Initiative

O-OJJDP-2026-172748Office of Juvenile Justice Delinquency Prevention

$750k

Everything open tagged Substance use

Source record: https://grants.nih.gov/grants/guide/pa-files/PAR-25-158.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.